Evonik plans to build additional world-scale methionine plant
Evonik Industries has started the planning stage for the construction of an additional world-scale plant complex in Singapore. The facility, which will produce the amino acid DL-methionine for animal nutrition, will have an annual production capacity of 150,000 metric tons and is expected to start operations in 2019. It still requires authorization from the Evonik committees.
Evonik’s most recent methionine plant took up its operations in Singapore in the fourth quarter of 2014 after a two-year construction period—precisely as planned—and operations are utilized according to plan. "The new complex will allow us to accompany market growth and further strengthen customer relations. As a reliable partner to our customers, we are of the strong conviction to realize this project in the given time frame as well," said Dr. Reiner Beste, the Chairman of the Board of Management at Evonik Nutrition & Care GmbH. In its new, backward-integrated production complex, Evonik will also produce all associated strategically relevant precursors.
The construction of the plant complex is planned next to the existing Evonik methionine plant on Jurong Island in Singapore. The location in Singapore allows Evonik to serve especially Asian growth markets well. The specialty chemicals company produces DL-methionine at world-scale plants in Antwerp (Belgium), Wesseling/Cologne (Germany), Mobile (Alabama, USA), and Singapore.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
